Compare Organon Pharma Indonesia Tbk. (SCPI) vs Urban Jakarta Propertindo Tbk. (URBN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Urban Jakarta Propertindo Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Urban Jakarta Propertindo Tbk. trades at Rp218 (market cap 717.53B, 90.4K 24h volume). The key difference: Urban Jakarta Propertindo Tbk. is far larger — about 6.9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | URBN | |
|---|---|---|
Market Cap | 104.4B | 717.53B |
Volume | — | 90.4K |
Lot | — | 904 |
Turnover | — | 19.97M |
Average Price | — | 220.94 |
Value | — | 19.97M |
Indicative Equilibrium Price | — | 218 |
Indicative Equilibrium Volume | — | 240 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Urban Jakarta Propertindo Tbk.
PT Urban Jakarta Propetindo (Company) was established in Jakarta under the framework of ForeignCapital Investment Law No. 1 year 1967 of the Republic of Indonesia as amended and revised by Law No. 11 year 1970, based on the notarial deed No. 62, dated May 9, 1995, of Sinta Susikto, S.H., has been amended several times by notarial deen No. 138 dated October 25, 1995 of the same notary.
Read more on URBN →
